Mohit Khera, MD, presented “2018 Update on Peyronie’s Disease – What’s Around the Bend” during the Jackson Hole Seminars on February 7, 2018 in Jackson Hole, Wyoming.

How to cite: Khera, Mohit. “2018 Update on Peyronie’s Disease: What’s Around the Bend” February 7, 2018. Accessed [date today]. https://grandroundsinurology.com/2018-update-on-peyronies-disease-whats-around-the-bend/

2018 Update on Peyronie’s Disease: What’s Around the Bend – Summary

Mohit Khera, MD, MBA, MPH, a panel member for the 2015 American Urological Association (AUA) Peyronie’s disease (PD) guidelines, discusses the prevalence of PD and its correlation to low testosterone. Furthermore, he summarizes the AUA statements on intralesional injections, penile stretching devices, and surgical options. He explains future directions in this setting, as well, including data from animal models testing platelet-rich plasma (PRP) and stem cells.

ABOUT THE AUTHOR

+ posts

Mohit Khera, MD, MBA, MPH, is a Professor of Urology at Baylor College of Medicine in Houston, Texas, where he holds the F. Brantley Scott Chair in Urology. He additionally serves Baylor College as the Director of the Laboratory for Andrology Research at McNair Medical Institute and the Medical Director of the Executive Health Program. Dr. Khera specializes in male and female sexual dysfunction, men’s health, male infertility, sexual dysfunction, declining testosterone levels in aging men, and hormone replacement therapy. His research interests include studies on the efficacy of botulinum toxin type A in treating Peyronie’s disease, genetic and epigenetic studies of post-finasteride syndrome patients, and testosterone replacement therapy.